COMMUNIQUÉS West-GlobeNewswire

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
23/07/2026
Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejection Serial monitoring of patients through donor-derived cell-free DNA (dd-cfDNA) [...]
Cato Supply Rebrands as Cato Healthcare Supply to Reflect Expanded Mission of Protecting Hospital Revenue Through Supply Chain Resilience
23/07/2026
DALLAS, July 23, 2026 (GLOBE NEWSWIRE) -- Cato Supply Inc. today announced its official rebrand to Cato Healthcare Supply , a strategic evolution that better reflects the company's mission. Cato stands for Completely [...]
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
23/07/2026
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter [...]
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
23/07/2026
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. [...]
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026
Aeroflow’s research provides health plans with key insights into why new mothers miss the vital six-week postpartum visit ASHEVILLE, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
23/07/2026
Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution GAITHERSBURG, Md., July 23, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. ( [...]
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development
23/07/2026
Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights IMNN-001 as one of the [...]
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
23/07/2026
Dr. Ascheim has over 30 years of clinical and executive experience advancing breakthrough therapies, including gene, cell, and biologics MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) a clinical [...]
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on [...]
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
ApolloMD Earns National and Atlanta Best and Brightest Companies to Work For® Honors for Second Straight Year
23/07/2026
ATLANTA, July 23, 2026 (GLOBE NEWSWIRE) -- ApolloMD has been named one of the 2026 Best and Brightest Companies to Work For ® both nationally and in Atlanta for the second consecutive year, recognizing continued [...]
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
23/07/2026
This support helps expand access to trusted clinical tools and patient resources designed to advance evidence-based pain management education POMPANO BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading [...]
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
23/07/2026
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE [...]
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Atsena [...]
Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays
23/07/2026
Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) -- Capillary testing is a patient-friendly option and ideal for difficult veins Capillary capability helps scale core labs’ testing offerings easily using [...]
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, [...]
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026
LAS VEGAS, July 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a developer of science-driven wellness products, today announces the successful completion of its commercial manufacturing and [...]

Pages